Vanguard Portfolio Management
INBX icon

Vanguard Portfolio Management’s Inhibrx INBX Stock Holding History

Vanguard Portfolio Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.6M Buy
122,557
+50,097
+69% +$5.02M ﹤0.01% 2152
2026
Q1 		$4.87M Buy
+72,460
New +$5.37M ﹤0.01% 2330

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management's INBX Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Inhibrx (INBX) stake by 69% in Q2 2026, buying an estimated $5.02M and bringing the position to 122,557 shares worth $11.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2152.

Vanguard Portfolio Management first reported a position in INBX in Q1 2026 and has held it in 2 quarters since. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Vanguard Portfolio Management held 122,557 shares of Inhibrx worth $11.6M as of Q2 2026.
  • Vanguard Portfolio Management bought 50,097 Inhibrx shares in Q2 2026, an estimated $5.02M.
  • Inhibrx made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2152 holding.
  • Vanguard Portfolio Management first reported a position in Inhibrx in Q1 2026 and has held it in 2 quarters since.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.